Pittcon addresses the synthetic psychedelics crisis; Boston 2025 to advance collaboration

Pittcon addresses the synthetic psychedelics crisis; Boston 2025 to advance collaboration

Pittcon 2024 in San Diego was a groundbreaking event for scientific innovation and collaboration. At the Laboratory Science Conference, scientists highlighted the public health threat posed by synthetic psychedelics in commercially available products such as edible gummies. Pittcon 2025 in Boston promises to update attendees on collaborations promoted in 2024 and continue to connect leaders in the cannabis and psychedelics industries.

Pittsburgh, PA – Pittcon, the leading international conference in laboratory science, is proud to announce the continued collaboration of three organizations brought together during the 2024 Psychedelics 101 Symposium. Pittcon is committed to cultivating scientific partnerships to address public health threats related to drug-related health at Pittcon 2025 in Boston.

Shimadzu Scientific Instruments, a Shimadzu group company in the USA; Rose City Labs, Oregon's leading environmental testing laboratory; and Oregon State University have collaborated on a scientific manuscript to be submitted before Pittcon 2025 in Boston. The manuscript summarizes their findings on psychedelic adulterers – namely “syndelics,” synthetic psychedelics hidden in products marketed as “natural” as commercially available.

These findings were first revealed during Pittcon 2024's Psychedelics 101: Emerging Trends, Applications and Advances in Psychedelics Quality Testing. In his presentation, Bjorn Fritzsche, an R&D chemist at Rose City Laboratories, detailed his discoveries that products marketed mushroom-based psychedelics do not contain any of the expected active ingredients.

Instead, these foods – sourced from convenience stores and head shops – were found to contain synthetic psychedelics and other compounds, including synthetic opioids and a horse's chambers. Fritzsche's research shows that there is an urgent need for standardized testing and regulation of psychedelic products to ensure consumer safety.

These synthetic compounds are far more potent and potentially harmful than natural psychedelics," emphasized Dan Huson, owner of Rose City Laboratories. Dr. Scott Kuzdzal, co-moderator of the symposium and vice president of the new strategy department at Shimadzu Scientific Instruments, added: "We need concerted efforts from QC testing laboratories, forensic toxicology labs, healthcare providers and regulators to address this growing public health threat."

In response to these discoveries, a working group was formed to improve analytical methods and raise awareness of the topic of synthetic psychedelics. Pittcon has created a collaborative platform where scientists can not only share their results but also drive the development of new analytical standards to ensure public health.

Richard B. Van Breeman, Director of Investigators for the Linus Pauling Institute's Department of Pharmaceutical Sciences, explained Pittcon's importance to the advancement of this area of ​​study:

Collaboration with Pittcon 2025 researchers will significantly improve the scientific community's ability to address Syndelic adulteration. As researchers at the Linus Pauling Institute, we are investigating new analytical techniques to detect these complex substances in collaboration with Rose City Labs. “

Pittcon 2025 will take place at the Boston Convention & Exhibition Center (BCEC). For the first time in its 75-year history, the event is taking place in the city. Attendees can expect more opportunities to connect and collaborate with industry experts through networking sessions and their renowned technical program.

Pittcon's comprehensive technical program is designed to showcase the latest developments in laboratory science and highlight emerging challenges in the field, such as the Syndelic crisis. The Cannabis & Psychedelics Track for 2025 continues many of the important themes previously established, such as: B. the development of robust, standardized testing protocols and the importance of regulatory needs.

Heather Juzwa, President of Pittcon 2025, expressed her excitement for attendees to experience what this year's event has to offer:

Pittcon has always been at the forefront of analytical innovation, and the Syndelic crisis is no exception. In 2025, we provide a collaborative space where the brightest minds in chemistry, toxicology and quality control can unite to protect public health. “

With the U.S. psychedelic mushroom market set to grow significantly in the coming years, now is the time to join Pittcon in Boston – to be part of conversations that are shaping the future of science.

For more information about attending Pittcon 2025, visit Visit

Sources: